Evidence map›Paper›PMID 37277541›Full record

ReviewStem cell reviews and reports2023

Cell Therapy for Androgenetic Alopecia: Elixir or Trick?

Yongcui Mao, Pinyan Liu, Jiayun Wei, Ye Xie, Qiuxia Zheng, Rui Li, Jia Yao

Open access · hybridAbstract readReview
In one paragraph

Review in Stem cell reviews and reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Hair Growth Effect and the Mechanisms ofInternational journal of molecular sciences · 2024
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yongcui MaoThe First Clinical Medical College of Lanzhou University, Lanzhou, China.
Pinyan LiuThe First Clinical Medical College of Lanzhou University, Lanzhou, China.
Jiayun WeiThe First Clinical Medical College of Lanzhou University, Lanzhou, China.
Ye XieThe First Clinical Medical College of Lanzhou University, Lanzhou, China.
Qiuxia ZhengThe First Clinical Medical College of Lanzhou University, Lanzhou, China.
Rui LiThe First Clinical Medical College of Lanzhou University, Lanzhou, China.
Jia YaoThe First Clinical Medical College of Lanzhou University, Lanzhou, China. yaoj06@lzu.edu.cn.ORCID 0000-0001-6463-3745
First Hospital of Lanzhou University · CNMinzu University of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Androgenetic alopecia is the most common cause of hair loss aggravated by increased life pressure, tension, and anxiety. Although androgenetic alopecia (AGA) does not significantly effect physical health, it can have serious negative impact on the mental health and quality of life of the patient. Currently, the effect of medical treatment for AGA is not idealistic, stem cell-based regenerative medicine has shown potential for hair regrowth and follicle repair, but the long-term effect and mechanism of stem cell therapy is not quite explicit. In this review, we summarize the methods, efficacy, mechanism, and clinical progress of stem cell therapies for AGA by now, hope it will present a more comprehensive view in this topic.

Indexed as

AlopeciaQuality of LifeCell- and Tissue-Based TherapyHairHumansStem CellsAndrogenetic AlopeciaCells TherapyConditioned MediaStem Cells

Identifiers

PMID37277541
PMCPMC10390634
OpenAlexW4379376022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.